ACO Leaders Say Mandatory Models Could Expand Value-Based Care, But Incentives Must Be Right

Why It Matters

The direction of mandatory models will shape provider behavior and Medicare’s ability to control costs while improving care quality.

Key Takeaways

• Mandatory ACO models could broaden value‑based care adoption
• CMS incentive design will determine provider participation
• Leaders warn penalties must align with quality goals
• Voluntary models risk lagging behind mandatory rollout
• Effective mandatory models could accelerate Medicare savings

Pulse Analysis

The Centers for Medicare & Medicaid Services (CMS) Innovation Center is intensifying its focus on mandatory payment models as a lever to deepen value‑based care across the Medicare program. Historically, many Accountable Care Organizations (ACOs) have participated voluntarily, allowing providers to test shared‑savings arrangements at their own pace. By shifting toward a mandatory framework, CMS hopes to standardize risk‑sharing, streamline reporting, and create a more predictable environment for large‑scale cost containment. This policy pivot reflects broader federal ambitions to move away from fee‑for‑service toward outcomes‑driven reimbursement.

ACO leaders, however, caution that the success of mandatory models hinges on the fine‑tuning of financial incentives and participation thresholds. If CMS sets overly aggressive downside risk or punitive penalties, providers may balk, fearing revenue volatility and operational strain. Conversely, incentives that reward genuine quality improvements—such as higher shared‑savings rates for meeting specific outcome benchmarks—can motivate broader enrollment. Leaders also stress the need for flexible participation criteria that accommodate diverse practice sizes, ensuring that smaller or rural ACOs are not excluded from the mandatory pool.

The broader implications for the healthcare market are substantial. Well‑designed mandatory models could accelerate Medicare’s projected savings, potentially freeing billions for other priority areas like drug pricing reform or health equity initiatives. For providers, aligning with mandatory structures may become a competitive differentiator, signaling a commitment to high‑quality, cost‑effective care. As the policy conversation evolves, stakeholders will watch closely how CMS balances risk, reward, and regulatory burden, shaping the next phase of the nation’s value‑based care transformation.